Popular Stories
Avise Analytics | Biopharmaceutical
350
archive,tag,tag-biopharmaceutical,tag-350,ajax_fade,page_not_loaded,,side_area_uncovered_from_content,qode-child-theme-ver-1.0.0,qode-theme-ver-7.4,wpb-js-composer js-comp-ver-5.0.1,vc_responsive

Biopharmaceutical Tag

  • All
  • Biotechnology
  • Cannabis
  • Investing Ideas
  • Macro
  • Miscellaneous
  • Sectors
  • Startups
  • Technologies
  • Trending
  • Uncategorized
A Cure for Narcolepsy No Longer a Pipe-Dream!

Narcolepsy is a sleep disorder that affects 1 in 2000 individuals and is caused by the loss or damage of a chemical named Hypocretin present in the hypothalamus, which is responsible for the regulation of sleep cycles and alerting the brain. This disorder is characterized...

Initiates Make-or-Break Phase 3 Clinical Trials in AngelMan Syndrome

Ovid Therapeutics (NASDAQ: OVID), a biopharmaceutical company developing novel therapeutics for rare neurological disorders, announced the launch of a crucial phase 3 clinical trial in Angelman Syndrome named NEPTUNE. OV101, its lead candidate for  the treatment of syndrome and Fragile X Syndrome is a delta-selective...

WordPress Video Lightbox Plugin